Brevan Howard Capital Management »

Regeneron Pharmaceuticals shares owned by Brevan Howard Capital Management

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Brevan Howard Capital Management from 13F filings

Historical chart of Brevan Howard Capital Management investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Brevan Howard Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Brevan Howard Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $3.0M 3.1k 962.49
2023-12-31 $1.0M 1.2k 878.29

More positions owned by Brevan Howard Capital Management

Ishares Msci Emerging Mkt In Msci Emg Mkt Etf (EEM)
Financial Select Sector Spdr Financial Call Option (XLF)
Ishares Iboxx H/y Corp Bond Iboxx Hi Yd Etf Call Option (HYG)
Ametek (AME)
Invesco QQQ Trust Series 1 Nasdaq100 BB:QQQ Unit Ser 1 (QQQ)
Ishares Msci Eafe Index Fund Msci Eafe Etf Call Option (EFA)
Consumer Staples Spdr Sbi Cons Stpls Call Option (XLP)
Ishares Russell 2000 Etf Russell 2000 Etf Call Option (IWM)
Health Care Select Secto Sbi Heathcare Call Option (XLV)
ISHARES 20plus YR TREAS 20 Yr Tr Bd Etf Call Option (TLT)
Spdr S&p Biotech Etf S&p Biotech Call Option (XBI)
Energy Select Sector Spdr Energy Call Option (XLE)
Spdr Metals & Mining Etf S&p Metals Mng Call Option (XME)
Streettracks Gold Trust Gold Shs Call Option (GLD)
SEMICONDUCTOR HOLDRs TRUST Semiconductr Etf (SMH)

View all positions for Brevan Howard Capital Management

Top funds holding Regeneron Pharmaceuticals

FMR
Vanguard Group
BlackRock
Jpmorgan Chase & Co
Geode Capital Management
Dodge & Cox
Franklin Resources
Morgan Stanley
Loomis, Sayles and
Wellington Management Company
Amundi
Northern Trust
Legal & General Group
Bank of America Corporation
T. Rowe Price Associates

View all funds holding Regeneron Pharmaceuticals